icon-folder.gif   Conference Reports for NATAP  
 
  15th European AIDS Conference (EACS)
October 21-24, 2015
Barcelona
Back grey_arrow_rt.gif
 
 
 
Switching From Boosted Atazanavir Plus Emtricitabine /Tenofovir Disoproxil Fumarate to a Tenofovir Alafenamide-Based Single-Tablet Regimen: Week-48 Data in Virologically Suppressed Adults
 
 
  Reported by Jules Levin
EACS 2015 Oct 21-24 Bacelona, Spain - 15th European AIDS Conference
 
B. Rijnders1, C. Stephan2, A. Lazzarin3, K. Squires4, M. McKellar5, S. Kiertiburanakul6, J.R. Arribas7, J. Gerstoft8, D. Murphy9, M. Bloch10, Y. Liu11, M. Fordyce12, S. McCallister12
1Erasmus MC, Internal Medicine and Infectious Diseases, Rotterdam, Netherlands, 2Universitats Klinikum Frankfurt, Frankfurt, Germany, 3University Vita-Salute San Raffaele, Malattie Infective, Milano, Italy, 4Thomas Jefferson University Hospital, Philadelphia, United States, 5Duke University, Durham, United States, 6Ramathibodi Hospital, Bangkok, Thailand, 7Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, 8Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark, 9Clinique Médicale l'Actuel, Montreal, Canada, 10Holdsworth House Research, Sydney, Australia, 11Gilead Sciences, Inc., Biometrics, Foster City, United States, 12Gilead Sciences, Inc., Clinical Research, Foster City, United States

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif

EACS11.gif

EACS12.gif

EACS13.gif

EACS14.gif

EACS15.gif

EACS16.gif